|
COQ5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.724800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.576000E-03 |
| Normal-vs-Stage2 |
4.277000E-01 |
| Normal-vs-Stage3 |
9.444800E-01 |
| Normal-vs-Stage4 |
1.978440E-01 |
| Stage1-vs-Stage2 |
5.139000E-01 |
| Stage1-vs-Stage3 |
1.187420E-01 |
| Stage1-vs-Stage4 |
5.396200E-01 |
| Stage2-vs-Stage3 |
5.090000E-01 |
| Stage2-vs-Stage4 |
3.384400E-01 |
| Stage3-vs-Stage4 |
1.494780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.720550E-03 |
| Normal-vs-AfricanAmerican |
1.481790E-01 |
| Normal-vs-Asian |
6.790000E-01 |
| Caucasian-vs-AfricanAmerican |
4.768000E-01 |
| Caucasian-vs-Asian |
9.678200E-01 |
| AfricanAmerican-vs-Asian |
8.458400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.402200E-04 |
| Normal-vs-Female |
8.802600E-01 |
| Male-vs-Female |
9.723900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.336800E-01 |
| Normal-vs-Extreme_Weight |
5.099600E-02 |
| Normal-vs-Obese |
6.614000E-02 |
| Normal-vs-Extreme_Obese |
1.779620E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.004600E-01 |
| Normal_Weight-vs-Obese |
3.243200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.686600E-01 |
| Extreme_Weight-vs-Obese |
8.948000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.782000E-01 |
| Obese-vs-Extreme_Obese |
3.820400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.702500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.063940E-02 |
| Normal-vs-Age(61-80Yrs) |
3.088100E-02 |
| Normal-vs-Age(81-100Yrs) |
6.384800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.932800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.275600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.779450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.904200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.181000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.18919999970002E-07 |
| Normal-VS-Type2 PRCC |
9.660600E-01 |
| Normal-VS-KIRP CIMP |
9.100200E-01 |
| Normal-VS-Unclassified PRCC |
4.393200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.160360E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.378780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.311600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.678800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.520800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.783600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.764800E-01 |
| Normal-vs-N1 |
5.389200E-01 |
| Normal-vs-N2 |
5.976400E-01 |
| N0-vs-N1 |
8.205400E-01 |
| N0-vs-N2 |
9.815700E-02 |
| N1-vs-N2 |
2.771200E-01 |
|
|
